Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Clinical importance of IL-22 cascade in IBD.

Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E.

J Gastroenterol. 2018 Apr;53(4):465-474. doi: 10.1007/s00535-017-1401-7. Epub 2017 Oct 26. Review.

2.

Targeted Metagenome Based Analyses Show Gut Microbial Diversity of Inflammatory Bowel Disease patients.

Qiu Z, Yang H, Rong L, Ding W, Chen J, Zhong L.

Indian J Microbiol. 2017 Sep;57(3):307-315. doi: 10.1007/s12088-017-0652-6. Epub 2017 May 12.

PMID:
28904415
3.

Expression of Interleukin-26 is upregulated in inflammatory bowel disease.

Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A.

World J Gastroenterol. 2017 Aug 14;23(30):5519-5529. doi: 10.3748/wjg.v23.i30.5519.

4.

Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.

Tian T, Wang Z, Zhang J.

Oxid Med Cell Longev. 2017;2017:4535194. doi: 10.1155/2017/4535194. Epub 2017 Jun 28. Review.

5.

Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.

Martini E, Krug SM, Siegmund B, Neurath MF, Becker C.

Cell Mol Gastroenterol Hepatol. 2017 Mar 23;4(1):33-46. doi: 10.1016/j.jcmgh.2017.03.007. eCollection 2017 Jul. Review.

6.

Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response.

Bhaumik S, Basu R.

Front Immunol. 2017 Mar 31;8:254. doi: 10.3389/fimmu.2017.00254. eCollection 2017. Review.

7.

Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.

Lopalco G, Lucherini OM, Lopalco A, Venerito V, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Cantarini L, Iannone F.

Front Immunol. 2017 Feb 27;8:200. doi: 10.3389/fimmu.2017.00200. eCollection 2017.

8.

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.

Kim DH, Cheon JH.

Immune Netw. 2017 Feb;17(1):25-40. doi: 10.4110/in.2017.17.1.25. Epub 2017 Feb 23. Review.

9.

rs2476601 polymorphism in PTPN22 is associated with Crohn's disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls.

Hedjoudje A, Cheurfa C, Briquez C, Zhang A, Koch S, Vuitton L.

Ann Gastroenterol. 2017;30(2):197-208. doi: 10.20524/aog.2017.0121. Epub 2017 Jan 5.

10.

IL23R single nucleotide polymorphisms could be either beneficial or harmful in ulcerative colitis.

Fischer S, Kövesdi E, Magyari L, Csöngei V, Hadzsiev K, Melegh B, Hegyi P, Sarlós P.

World J Gastroenterol. 2017 Jan 21;23(3):447-454. doi: 10.3748/wjg.v23.i3.447.

11.

The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity.

Karban A, Feldman T, Waterman M, Leiba R, Efrati E.

Medicine (Baltimore). 2016 Dec;95(51):e5611. doi: 10.1097/MD.0000000000005611.

12.

Human Intestinal Barrier Function in Health and Disease.

König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer RJ.

Clin Transl Gastroenterol. 2016 Oct 20;7(10):e196. doi: 10.1038/ctg.2016.54. Review.

13.

A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.

Gupta A, Juyal G, Sood A, Midha V, Yamazaki K, Vich Vila A, Esaki M, Matsui T, Takahashi A, Kubo M, Weersma RK, Thelma BK.

Eur J Hum Genet. 2016 Jan;25(1):111-122. doi: 10.1038/ejhg.2016.131. Epub 2016 Oct 19.

14.

Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition.

Woo YR, Lim JH, Cho DH, Park HJ.

Int J Mol Sci. 2016 Sep 15;17(9). pii: E1562. doi: 10.3390/ijms17091562. Review.

15.

Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases.

Nakka P, Raphael BJ, Ramachandran S.

Genetics. 2016 Oct;204(2):783-798. Epub 2016 Aug 3.

16.

Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility.

Ye BD, McGovern DP.

Expert Rev Clin Immunol. 2016 Oct;12(10):1091-107. doi: 10.1080/1744666X.2016.1184972. Epub 2016 Jun 15. Review.

17.

Association of REL polymorphisms and outcome of patients with septic shock.

Toubiana J, Courtine E, Tores F, Asfar P, Daubin C, Rousseau C, Ouaaz F, Marin N, Cariou A, Chiche JD, Mira JP.

Ann Intensive Care. 2016 Dec;6(1):28. doi: 10.1186/s13613-016-0130-z. Epub 2016 Apr 8.

18.

Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Wu W, Chen F, Liu Z, Cong Y.

Inflamm Bowel Dis. 2016 Jun;22(6):1473-82. doi: 10.1097/MIB.0000000000000775. Review.

19.

Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future.

Sifuentes-Dominguez L, Patel AS.

F1000Res. 2016 Feb 29;5. pii: F1000 Faculty Rev-240. doi: 10.12688/f1000research.7440.1. eCollection 2016. Review.

20.

IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking.

Sivanesan D, Beauchamp C, Quinou C, Lee J, Lesage S, Chemtob S, Rioux JD, Michnick SW.

J Biol Chem. 2016 Apr 15;291(16):8673-85. doi: 10.1074/jbc.M116.715870. Epub 2016 Feb 17.

Supplemental Content

Support Center